Sequencing Could Augment Other Newborn Screening Approaches, NC NEXUS Study Finds
Sequencing-based newborn screening could not identify all children with metabolic disorders or hearing loss, but could interrogate a larger number of conditions.
Fox Chase Cancer Center, Genome Profiling Partner on Immune Epigenetic Research
GenPro will use its EpiMarker machine-learning platform to identify a network of genomic DNA methylation sites in patients' circulating immune cells that may be predictive of drug response.
Natera Partners With Fox Chase to Evaluate ctDNA Cancer Assay
The Signatera research-use-only assay monitors cancer treatment and assesses minimal residual disease, and is customized for individual patients.
Clear Genetics is developing a chatbot to help make genetic counseling accessible, and genetic counselors say it could help handle straightforward cases.
Stanford, Fox Chase Researchers ID Relative Risk of 25 Mutations Tied to Breast, Ovarian Cancer
The Stanford University and Fox Chase Cancer Center team found that some mutations dramatically increased cancer risk, while others had a more modest effect.